Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Medpace Holdings, Inc.

Medpace is a drug and biologic contract research organization (CRO) that offers comprehensive services for clinical development, providing integrated solutions through a full-service model.

COM:MEDPACE

Medpace

Last Close

341.82

22/11 21:00

Market Cap

12.98B

Beta: -

Volume Today

351.39K

Avg: -

Financials Not Available